רילוטק ישראל - עברית - Ministry of Health

רילוטק

sanofi israel ltd - riluzole - טבליות מצופות פילם - riluzole 50 mg - riluzole - riluzole - for the treatment of patients with amyotrophic lateral sclerosis (als).

פלקווניל ישראל - עברית - Ministry of Health

פלקווניל

sanofi israel ltd - hydroxychloroquine sulfate - טבליות מצופות פילם - hydroxychloroquine sulfate 200 mg - hydroxychloroquine - hydroxychloroquine - plaquenil is indicated for the suppressive treatment and treatment of acute attacks of malaria due to plasmodium vivax, p. malaria. p. ovale and susceptible strains of p. falciparum it is also indicated for the treatment of discoid and sustemic lupus erythematosus and rheumatoid arthritis.

טלפסט 180 מ"ג ישראל - עברית - Ministry of Health

טלפסט 180 מ"ג

sanofi - aventis israel ltd - fexofenadine hydrochloride 180 mg - film coated tablets - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

קיאקסאלאט ישראל - עברית - Ministry of Health

קיאקסאלאט

sanofi israel ltd - polystyrene sulphonate sodium - אבקה להכנת תרחיף - polystyrene sulphonate sodium 99.934 % - polystyrene sulfonate - polystyrene sulfonate - treatment of hyperkalemia.

אימווקס פוליו ישראל - עברית - Ministry of Health

אימווקס פוליו

sanofi israel ltd - poliovirus type 1 inactivated; poliovirus type 2 inactivated; poliovirus type 3 inactivated - תרחיף להזרקה - poliovirus type 1 inactivated 40 u/vial; poliovirus type 2 inactivated 8 u/vial; poliovirus type 3 inactivated 32 u/vial - poliomyelitis vaccines - prophylaxis of poliomyelitis.

טריטייס 1.25 מג ישראל - עברית - Ministry of Health

טריטייס 1.25 מג

sanofi israel ltd - ramipril - טבליה - ramipril 1.25 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

טריטייס 2.5 מג ישראל - עברית - Ministry of Health

טריטייס 2.5 מג

sanofi israel ltd - ramipril - טבליה - ramipril 2.5 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

טריטייס 5 מג ישראל - עברית - Ministry of Health

טריטייס 5 מג

sanofi israel ltd - ramipril - טבליה - ramipril 5 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

טוברסול ישראל - עברית - Ministry of Health

טוברסול

sanofi israel ltd - tuberculin purified protein - תמיסה להזרקה - tuberculin purified protein 5 tu / 0.1 ml - tuberculosis diagnostics - an aid in the detection of infection with mycobacterium tuberculosis.

זאלטראפ ישראל - עברית - Ministry of Health

זאלטראפ

sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.